{
  "id": "cluster_5_doc3",
  "content": "Policy memorandum HCAR-2024-039 restricts cellular immunotherapy coverage to tertiary centers effective Q2 2024. Requires documented treatment failure of two biologics. Exception process: submit via portal REF882-CD with hematology consult. Impacts 18 patients in Mountain West region. Implementation date: May 1, 2024.",
  "metadata": {
    "format": "policy_document"
  }
}